1. Biochemistry and Chemical Biology
  2. Stem Cells and Regenerative Medicine
Download icon

The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells

  1. Yick W Fong
  2. Jaclyn J Ho
  3. Carla Inouye
  4. Robert Tjian  Is a corresponding author
  1. Brigham and Women's Hospital, United States
  2. Howard Hughes Medical Institute, University of California, Berkeley, United States
  3. Howard Hughes Medicial Institute, University of California, Berkeley, United States
Research Article
  • Cited 23
  • Views 2,626
  • Annotations
Cite this article as: eLife 2014;3:e03573 doi: 10.7554/eLife.03573

Abstract

Acquisition of pluripotency is driven largely at the transcriptional level by activators OCT4, SOX2, and NANOG that must in turn cooperate with diverse coactivators to execute stem cell-specific gene expression programs. Using a biochemically defined in vitro transcription system that mediates OCT4/SOX2 and coactivator-dependent transcription of the Nanog gene, we report the purification and identification of the dyskerin (DKC1) ribonucleoprotein complex as an OCT4/SOX2 coactivator whose activity appears to be modulated by a subset of associated small nucleolar RNAs (snoRNAs). The DKC1 complex occupies enhancers and regulates the expression of key pluripotency genes critical for self-renewal in embryonic stem (ES) cells. Depletion of DKC1 in fibroblasts significantly decreased the efficiency of induced pluripotent stem (iPS) cell generation. This study thus reveals an unanticipated transcriptional role of the DKC1 complex in stem cell maintenance and somatic cell reprogramming.

Article and author information

Author details

  1. Yick W Fong

    Brigham and Women's Hospital, Cambridge, United States
    Competing interests
    No competing interests declared.
  2. Jaclyn J Ho

    Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  3. Carla Inouye

    Howard Hughes Medicial Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  4. Robert Tjian

    Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States
    For correspondence
    tjianr@hhmi.org
    Competing interests
    Robert Tjian, Robert Tjian is President of the Howard Hughes Medical Institute (2009-present), one of the three founding funders of eLife, and a member of eLife's Board of Directors.

Reviewing Editor

  1. Benjamin J Blencowe, University of Toronto, Canada

Publication history

  1. Received: June 4, 2014
  2. Accepted: November 19, 2014
  3. Accepted Manuscript published: November 19, 2014 (version 1)
  4. Version of Record published: December 10, 2014 (version 2)

Copyright

© 2014, Fong et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,626
    Page views
  • 281
    Downloads
  • 23
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)